Zobrazeno 1 - 10
of 109
pro vyhledávání: '"Thomas W P, Friedl"'
Autor:
Davut Dayan, Stefan Lukac, Brigitte Rack, Florian Ebner, Visnja Fink, Elena Leinert, Kristina Veselinovic, Sabine Schütze, Ziad El Taie, Wolfgang Janni, Thomas W. P. Friedl
Publikováno v:
Breast Cancer Research, Vol 25, Iss 1, Pp 1-15 (2023)
Abstract Background Invasive lobular breast carcinomas (ILC) have different histological features compared to non-special type carcinomas (NST), but the effect of histological subtypes on survival is controversial. In this study, we compared clinicop
Externí odkaz:
https://doaj.org/article/040a53ead07c4e1c83adc37b34bc632c
Autor:
Amelie de Gregorio, Lothar Häberle, Peter A. Fasching, Volkmar Müller, Iris Schrader, Ralf Lorenz, Helmut Forstbauer, Thomas W. P. Friedl, Emanuel Bauer, Nikolaus de Gregorio, Miriam Deniz, Visnja Fink, Inga Bekes, Ulrich Andergassen, Andreas Schneeweiss, Hans Tesch, Sven Mahner, Sara Y. Brucker, Jens-Uwe Blohmer, Tanja N. Fehm, Georg Heinrich, Krisztian Lato, Matthias W. Beckmann, Brigitte Rack, Wolfgang Janni
Publikováno v:
Breast Cancer Research, Vol 22, Iss 1, Pp 1-11 (2020)
Abstract Background When chemotherapy is indicated in patients with early breast cancer, regimens that contain anthracyclines and taxanes are established standard treatments. Gemcitabine has shown promising effects on the response and prognosis in pa
Externí odkaz:
https://doaj.org/article/41e6c37d4d19434583b0e8de81ad13a2
Autor:
Marianna Alunni-Fabbroni, Leonie Majunke, Elisabeth K. Trapp, Marie Tzschaschel, Sven Mahner, Peter A. Fasching, Tanja Fehm, Andreas Schneeweiss, Thomas Beck, Ralf Lorenz, Thomas W. P. Friedl, Wolfgang Janni, Brigitte Rack, on behalf of the SUCCESS Study Group
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-12 (2018)
Abstract Background microRNAs (miRNAs) are considered promising cancer biomarkers, showing high reliability, sensitivity and stability. Our study aimed to identify associations between whole blood miRNA profiles, presence of circulating tumor cells (
Externí odkaz:
https://doaj.org/article/35021f3d4cbf4fba95d7c6d5747e931e
Autor:
Amelie de Gregorio, Wolfgang Janni, Thomas W. P. Friedl, Ulrike Nitz, Brigitte Rack, Andreas Schneeweiss, Ronald Kates, Tanja Fehm, Hans Kreipe, Matthias Christgen, Sherko Kümmel, Elisabeth Trapp, Rachel Wuerstlein, Andreas Hartkopf, Michael Clemens, Toralf Reimer, Lothar Häberle, Peter A. Fasching, Oleg Gluz, Nadia Harbeck
Publikováno v:
British Journal of Cancer. 126:1715-1724
Background Anthracycline/cyclophosphamide-taxane-containing chemotherapy (AC-T) is the standard of care in the adjuvant treatment of HER2-negative early breast cancer (EBC), but recent studies suggest omission of anthracyclines for reduced toxicity w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::28826a3ebb886dca9cc147eb973963b0
https://doi.org/10.1038/s41416-021-01690-6
https://doi.org/10.1038/s41416-021-01690-6
Autor:
Maria, Kersten, Andrea, Korzoum, Thomas W P, Friedl, Sabine, Schütze, Marie, Tzschaschel, Julia, Fritz, Wolfgang, Janni, Katharina, Hancke
Publikováno v:
The European Journal of Contraception & Reproductive Health Care. 27:95-101
To study trends regarding the use of contraceptive methods and digital health modalities and to identify target groups of natural family planning (NFP).Using an online questionnaire specifically developed for this study in German (utilizing the onlin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::973ac0a85abd4f87ac0bd20f767f0bec
https://doi.org/10.1080/13625187.2021.2021585
https://doi.org/10.1080/13625187.2021.2021585
Autor:
André Franken, Annika Kraemer, Alicia Sicking, Meike Watolla, Mahdi Rivandi, Liwen Yang, Jens Warfsmann, Bernhard M. Polzer, Thomas W. P. Friedl, Franziska Meier-Stiegen, Nikolas H. Stoecklein, Davut Dayan, Sabine Riethdorf, Volkmar Mueller, Klaus Pantel, André Koch, Andreas D. Hartkopf, Natalia Krawczyk, Eugen Ruckhaeberle, Dieter Niederacher, Tanja Fehm, Hans Neubauer
Background Circulating tumour cells (CTCs) are mainly enriched based on the epithelial cell adhesion molecule (EpCAM). Although it was shown that an EpCAM low-expressing CTC fraction is not captured by such approaches, knowledge about its prognostic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2135e5daa3637915ae372f9de7c8d8b5
https://publica.fraunhofer.de/handle/publica/441437
https://publica.fraunhofer.de/handle/publica/441437
Sex-specific differences in DNA double-strand break repair of cycling human lymphocytes during aging
Autor:
Michael Milyavsky, Michael Denkinger, Melanie Rall-Scharpf, Thomas W. P. Friedl, Lisa Wiesmüller, Shahar Biechonski
Publikováno v:
Aging (Albany NY)
The gender gap in life expectancy and cancer incidence suggests differences in the aging process between the sexes. Genomic instability has been recognized as a key factor in aging, but little is known about sex-specific differences. Therefore, we an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dbbc180ccf6e673228c8aaa7c1bb3cc2
https://doi.org/10.18632/aging.203519
https://doi.org/10.18632/aging.203519
Autor:
Fabienne Schochter, Thomas W. P. Friedl, Amelie deGregorio, Sabrina Krause, Jens Huober, Brigitte Rack, Wolfgang Janni
Publikováno v:
Cells, Vol 8, Iss 11, p 1412 (2019)
In recent years, breast cancer treatment has become increasingly individualized. Circulating tumor cells (CTCs) have the potential to move personalized medicine another step forward. The prognostic relevance of CTCs has already been proven both in ea
Externí odkaz:
https://doaj.org/article/6a41aa12cdde4a55bf1ac8c7c772dd6b
Autor:
Wolfgang Janni, Franziska Meier-Stiegen, Jens Uwe Blohmer, Tanja Fehm, Eugen Ruckhaeberle, Andreas Schneeweiss, Maggie Banys-Paluchowski, Diethelm Wallwiener, Jens Huober, Christian R. Loehberg, Oliver Hoffmann, Peter A. Fasching, Andreas D. Hartkopf, Sabine Riethdorf, Brigitte Rack, Volkmar Mueller, Thomas W. P. Friedl, Pauline Wimberger, Lothar Müller
Publikováno v:
Cancer Research. 81:PD3-12
Background: It is well-known that tumor biology may change during the course of the disease due to clonal evolution, and such changes might have important implications for response to targeted treatments. Circulating tumor cells (CTCs) could serve as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9fb3f32792b953ed6db77901466d94ca
https://doi.org/10.1158/1538-7445.sabcs20-pd3-12
https://doi.org/10.1158/1538-7445.sabcs20-pd3-12
Autor:
Tanja Fehm, Luc Dirix, Stefan Sleijfer, Paola Gazzaniga, José A. García-Sáenz, Carlos Caldas, Rita Zamarchi, Karthik V. Giridhar, Lorenzo Gerratana, Massimo Cristofanilli, Luis Manso, Dimitrios Mavroudis, Kostandinos Sideras, Meredith M. Regan, Zefei Jiang, Michail Ignatiadis, Rafael Gisbert-Criado, William E. Barlow, François-Clément Bidard, Thomas W. P. Friedl, Klaus Pantel, Evi Lianidou, Daniele Generali, Jean-Yves Pierga, Sabine Riethdorf, Tracy C. Yab, Mark Jesus M. Magbanua, Jose Vidal-Martinez, Jeffrey B. Smerage, Brigitte Rack, Hope S. Rugo, Catherine Alix-Panabières, Lisa A. Carey, Minetta C. Liu, Volkmar Müller, William Jacot, Wolfgang Janni, Elisabetta Munzone, Justin Stebbing, Leon W.M.M. Terstappen, Daniel F. Hayes
Publikováno v:
Cancer Research. 81:GS4-08
Background: Several studies suggest clinical utility of serial circulating tumor cell (CTC) enumeration as a means of assessing response status in metastatic breast cancer (MBC). The aim of this study is to conduct a comprehensive pooled analysis com
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4fb1a0b5d7f46b212d1021bc8fdfcf12
https://doi.org/10.1158/1538-7445.sabcs20-gs4-08
https://doi.org/10.1158/1538-7445.sabcs20-gs4-08